About this Event
Our 2025 Autumn Research Update Meeting will be taking place once again at the renowned Royal Society of Medicine (RSM), Wimpole Street, London on Monday 10 November, where guests can look forward to an engaging agenda featuring the latest updates from our funded research.
Our next meeting will focus on multi-arm, multi-stage (MAMS) clinical trial platforms, an approach that is revolutionising Parkinson’s research by testing multiple treatments at once against a single placebo and speeding the development of new therapies. Attendees will hear presentations from two upcoming MAMS projects: EJS ACT-PD, a UK-based MAMS platform, and SLEIPNIR, a multi-arm clinical trial platform recently launched in Norway.
Agenda (to be finalised)
2pm: Welcome and opening remarks
Helen Matthews, CEO, Cure Parkinson’s
2:05pm: Looking forward: Cure Parkinson’s Research Strategy +Q&A
Dr Simon Stott, Director of Research, Cure Parkinson’s
2:30pm: SLEIPNIR: A multi-arm platform for de-risking Parkinson’s treatments +Q&A
Prof Charalampos Tzoulis, University of Bergen
3:15pm: Tea and coffee break with a chance to learn more about clinical trial opportunities at our interactive information tables
3:45pm: International MAMS Consortium: Coordinating Parkinson’s trials worldwide
Dr Chirine Katrib, France Parkinson
4:00pm: An update on EJS ACT-PD
Georgia Mills, Research Project Manager, UCL
4:30pm: TBD
5pm: Closing remarks - Cure Parkinson’s
5:05pm: Drinks reception
Event Venue & Nearby Stays
The Royal Society of Medicine, 1 Wimpole Street, London, United Kingdom
GBP 0.00
